How many institutional investors hold ENLV?

2 tracked institutional investors disclosed a position in ENLV (ENLIVEX THERAPEUTICS LTD) in their most recent 13F filing.

Who is the largest institutional holder of ENLV?

Cathie Wood, ARK Investment Management, holds the largest disclosed position in ENLV, valued at $1M.

Where does this ENLV ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ENLV — ENLIVEX THERAPEUTICS LTD

Name: ENLIVEX THERAPEUTICS LTD (ENLV) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ENLV?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net accumulation · 1 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their ENLV position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence

+1 tracked investor added or increased positions last quarter (Cathie Wood)
+2 tracked investors reported holding ENLV at their latest filing
+Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About ENLIVEX THERAPEUTICS LTD (ENLV)

ENLIVEX THERAPEUTICS LTD (ENLV) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $1M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ENLV

100

/100

Strong Institutional Accumulation

Added / Increased2

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track ENLV

/100

Undiscovered

2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded

151015+

ENLV Ownership Composition

How ENLIVEX THERAPEUTICS LTD is held across tracked investor types, based on reported 13F positions.

Dominant Type

Growth & Innovation

96% of tracked value

Institutions

tracked investors

Total Reported

$1.4M

combined 13F value

Growth & Innovation96.4%
Multi-Strategy / Quant3.6%

Growth & Innovation(1)

96.4%

Multi-Strategy / Quant(1)

3.6%

Tracked investors currently reporting ENLV

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Cathie Wood	ARK Investment Management	2.4M	$1.3M	0.01%	Jun 30, 2026
Ken Griffin	Citadel Advisors	88.4K	$48.6K	0.00%	Jun 30, 2026

Cathie WoodJun 30, 2026
ARK Investment Management
Shares
2.4M
Value
$1.3M
% Portfolio
0.01%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
88.4K
Value
$48.6K
% Portfolio
0.00%

Previously held ENLV

These investors reported ENLV in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Izzy Englander	Millennium Management	11.8K	$11K	Mar 31, 2026

Recent activity

Investor	Action	Δ %	Current value	Filing date
Cathie Wood	New	—	$584.4K	May 12, 2026
Cathie Wood	Increased	279.23%	$1.3M	Aug 14, 2026

Cathie Wood
New
$584.4KMay 12, 2026
Cathie Wood
Increased
$1.3M(279.23%)Aug 14, 2026

Frequently asked questions

How many institutional investors hold ENLV?: 2 tracked institutional investors disclosed a position in ENLV (ENLIVEX THERAPEUTICS LTD) in their most recent 13F filing.
Who is the largest institutional holder of ENLV?: Cathie Wood, ARK Investment Management, holds the largest disclosed position in ENLV, valued at $1M.
Did institutional ownership of ENLV increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 0 fully exited ENLV.
Where does this ENLV ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.